|
|
|
|
Lensar Inc (NASDAQ: LNSR) |
|
Price: $7.6900
$-0.36 
-4.472%
|
| Day's High:
| $8.180000305175781
| Week Perf:
| -10.37 %
|
| Day's Low: |
$ 7.69 |
30 Day Perf: |
22.26 % |
| Volume (M): |
32,970 |
52 Wk High: |
$ 12.94 |
| Volume (M$): |
$ 0 |
52 Wk Avg: |
$8.98 |
| Open: |
$8.12 |
52 Wk Low: |
$4.95 |
|
|
| Market Capitalization (Millions $) |
177 |
| Shares
Outstanding (Millions) |
23 |
| Employees |
150 |
| Revenues (TTM) (Millions $) |
60 |
| Net Income (TTM) (Millions $) |
33 |
| Cash Flow (TTM) (Millions $) |
0 |
| Capital Exp. (TTM) (Millions $) |
0 |
Business Description
Lensar Inc. is a medical technology company that specializes in developing and manufacturing advanced laser systems for cataract surgery and other ophthalmic procedures. The company's flagship product is the Lensar Laser System, which integrates precise imaging and measurement technologies with femtosecond laser technology to improve the precision and outcomes of cataract surgeries. The Lensar Laser System offers surgeons improved control and accuracy during procedures, leading to faster recovery times and better patient outcomes. The company aims to innovate and advance ophthalmic care by developing cutting-edge technologies and providing reliable solutions for eye surgeons globally.
Company Address: 2800 Discovery Drive Orlando 32826 FL
Company Phone Number: 536-7271 Stock Exchange / Ticker: NASDAQ LNSR
|
|
|
|
|
|
|
| Stock Performances by Major Competitors |
|
|
|
| Merger and Acquisition
Published Mon, Mar 24 2025 12:00 PM UTC
Alcon s Strategic Acquisition of LENSAR: A Game Changer in Cataract SurgeryIn a significant move to bolster its position in the eye care sector, Alcon (SIX/NYSE: ALC), a global leader in eye care solutions, has announced a definitive merger agreement to acquire LENSAR, Inc. (NASDAQ: LNSR). The announcement, made on March 24, 2025, signals a strategic shift towards enhancing...
|
| Shares
Published Tue, Mar 4 2025 12:03 AM UTC
LENSAR Inc. Announces Inducement Grants for New Employees Amid Growing Market PresenceORLANDO, Fla. In a strategic move to bolster its workforce and enhance its competitive edge, LENSAR, Inc. (Nasdaq: LNSR) today announced the grant of stock options to two newly-hired non-executive employees. This decision was made by a majority of the independent members of the company s ...
|
| Shares
Published Tue, Feb 4 2025 12:34 AM UTC
LENSAR, Inc. Solidifies Growth Strategy: Inducement Grants Exemplify Commitment to Talent Acquisition Amid Market GainsOn February 3, 2025, LENSAR, Inc. (Nasdaq: LNSR) made a significant move in its talent management strategy by granting stock options to two newly-hired non-executive employees. The board of directors, with a majority of independent members, approved the iss...
|
| Stock Market Announcement
Published Mon, Dec 9 2024 9:01 PM UTC
In an era where competitive talent acquisition is crucial for companies looking to innovate and thrive, LENSAR Inc. (Nasdaq: LNSR) is taking decisive steps to bolster its workforce. On December 9, 2024, LENSAR, a company specializing in advanced laser technology for eye surgeries, announced the granting of stock options to newly-hired non-executive employees as part of its s...
|
| Shares
Published Fri, Nov 1 2024 10:32 PM UTC
LENSAR, Inc. Grants Stock Options to New Hires Amid Celebratory Milestone in Cataract Surgery InnovationsOn November 1, 2024, LENSAR, Inc. (NASDAQ: LNSR), a prominent player in the field of ophthalmic laser technology, announced a notable step in its growth strategy by granting stock options to two newly-hired non-executive employees. This decision, made by the majority of i...
|
Fundamental Analysis
| Per Share |
Current |
| Earnings (TTM) |
-0.33 $ |
| Revenues (TTM) |
2.62 $
|
| Cash Flow (TTM) |
0 $ |
| Cash |
0.59 $
|
| Book Value |
0.65 $
|
| Dividend (TTM) |
0 $ |
| Efficiency
|
Current |
| Revenue per Employee
(TTM) |
401,760 |
| Net
Income per Employee (TTM) |
219,520 |
| Receivable Turnover Ratio (TTM) |
10.33 |
| Inventory Turnover Ratio (TTM) |
1.38 |
| Asset Turnover Ratio (TTM) |
0.88 |
|
|
| Per Share |
|
| Earnings (TTM) |
-0.33 $
|
| Revenues (TTM) |
2.62 $ |
| Cash Flow (TTM) |
0 $ |
| Cash |
0.59 $
|
| Book Value |
0.65 $ |
| Dividend (TTM) |
0 $ |
|
|
| |
| Product |
|
 140.15 % |
of total Revenue |
| Service |
|
20.32 % |
of total Revenue |
| US |
|
114.77 % |
of total Revenue |
| Asia |
|
19.49 % |
of total Revenue |
| Europe |
|
25.43 % |
of total Revenue |
| Other |
|
0.78 % |
of total Revenue |
| Member |
|
181.41 % |
of total Revenue |
|
|
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.
